☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
(ARGX-110)
Innovate and Massachusetts General Hospital Collaborates to Develop Larazotide for Alcoholic Liver Disease
December 5, 2018
Cilag Acquires Exclusive Worldwide Rights of Argenx's Cusatuzumab (ARGX-110) for $1.6B
December 4, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.